Sinusoidal obstruction syndrome (hepatic veno-occlusive disease).

[1]  N. Chao.  How I treat sinusoidal obstruction syndrome. , 2014, Blood.

[2]  E. Oki,et al.  Splenic volume may be a useful indicator of the protective effect of bevacizumab against oxaliplatin-induced hepatic sinusoidal obstruction syndrome. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[3]  N. Santoro,et al.  Non‐activated protein C rescue treatment in Wilms tumour associated hepatic sinusoidal obstructive syndrome , 2014, Pediatric blood & cancer.

[4]  K. Mehta,et al.  A nonhuman primate model of human radiation-induced venocclusive liver disease and hepatocyte injury. , 2014, International journal of radiation oncology, biology, physics.

[5]  P. Veys,et al.  BCSH/BSBMT guideline: diagnosis and management of veno‐occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation , 2013, British journal of haematology.

[6]  J. Mann,et al.  The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome , 2013, British Journal of Cancer.

[7]  Sukjoong Oh,et al.  Hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation in adult patients with idiopathic aplastic anemia. , 2013, Leukemia research.

[8]  M. Tuncer,et al.  Coexisting or underlying risk factors of hepatic veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients receiving prophylaxis. , 2013, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

[9]  J. Mathers,et al.  Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model , 2013, Journal of hepatology.

[10]  S. Lee,et al.  Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA? , 2013, Bone Marrow Transplantation.

[11]  Y. Morine,et al.  Oxaliplatin‐related sinusoidal obstruction syndrome mimicking metastatic liver tumors , 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

[12]  Consolato Sergi,et al.  Hepatotoxic botanicals - an evidence-based systematic review. , 2013, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[13]  L. Zeng,et al.  A Murine Model of Hepatic Veno-occlusive Disease Induced by Allogeneic Hematopoietic Stem Cell Transplantation , 2013, Cell Biochemistry and Biophysics.

[14]  C. Dejong,et al.  Hyaluronic Acid as a Marker of Hepatic Sinusoidal Obstruction Syndrome Secondary to Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastases , 2013, Annals of Surgical Oncology.

[15]  M. Tallman,et al.  Incidence of sinusoidal obstruction syndrome following Mylotarg (gemtuzumab ozogamicin): a prospective observational study of 482 patients in routine clinical practice , 2013, International Journal of Hematology.

[16]  K. Myers,et al.  High-dose methylprednisolone for veno-occlusive disease of the liver in pediatric hematopoietic stem cell transplantation recipients. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[17]  R. Setia,et al.  Treosulfan-thiotepa-fludarabine-based conditioning regimen for allogeneic transplantation in patients with thalassemia major: a single-center experience from north India. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[18]  E. Wisse,et al.  Glutathione S-transferase M1-null genotype as risk factor for SOS in oxaliplatin-treated patients with metastatic colorectal cancer , 2013, British Journal of Cancer.

[19]  J. Mann,et al.  An experimental study to identify the potential role of pharmacogenomics in determining the occurrence of oxaliplatin-induced liver injury , 2012, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[20]  J. Church,et al.  Hepatic veno-occlusive disease with immunodeficiency (VODI): first reported case in the U.S. and identification of a unique mutation in Sp110. , 2012, Clinical immunology.

[21]  Y. Koyama,et al.  Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9. , 2012, Journal of hepatology.

[22]  J. Ziegler,et al.  Clinical, molecular, and cellular immunologic findings in patients with SP110-associated veno-occlusive disease with immunodeficiency syndrome. , 2012, The Journal of allergy and clinical immunology.

[23]  Douglas B. Johnson,et al.  How can we reduce hepatic veno-occlusive disease-related deaths after allogeneic stem cell transplantation? , 2012, Experimental hematology.

[24]  P. Bachellier,et al.  Liver Injury Due to Chemotherapy-induced Sinusoidal Obstruction Syndrome Is Associated with Sinusoidal Capillarization , 2012, Annals of Surgical Oncology.

[25]  G. Lin,et al.  Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids , 2012, Journal of digestive diseases.

[26]  R. D'Agostino,et al.  Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Stem Cell Transplant (SCT) and Non-SCT Patients (Pts): Early Intervention Improves Outcome - Updated Results of a Treatment IND Expanded Access Protocol , 2011 .

[27]  M. Díaz-Beyá,et al.  The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[28]  P. Chevallier,et al.  Fludarabine, antithymocyte globulin, and very low-dose busulfan for reduced-intensity conditioning before allogeneic stem cell transplantation in patients with lymphoid malignancies. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[29]  R. Alaggio,et al.  Veno‐occlusive disease in pediatric patients affected by Wilms tumor , 2011, Pediatric blood & cancer.

[30]  D. Samuel,et al.  Significance of isolated hepatic veno‐occlusive disease/sinusoidal obstruction syndrome after liver transplantation , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[31]  D. Lambrechts,et al.  Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial , 2011, The Lancet.

[32]  S. Tauzin,et al.  Gene Expression Profiling Provides Insights into Pathways of Oxaliplatin-Related Sinusoidal Obstruction Syndrome in Humans , 2011, Molecular Cancer Therapeutics.

[33]  T. Gruenberger,et al.  Sinusoidal Obstruction Syndrome Impairs Long-Term Outcome of Colorectal Liver Metastases Treated with Resection after Neoadjuvant Chemotherapy , 2011, Annals of Surgical Oncology.

[34]  P. Richardson,et al.  Prediction of veno-occlusive disease using biomarkers of endothelial injury. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[35]  Allen R. Chen,et al.  Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[36]  Jun-ji Ma,et al.  New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. , 2010, Journal of hepatology.

[37]  F. Goldwasser,et al.  Predicting High Grade Lesions of Sinusoidal Obstruction Syndrome Related to Oxaliplatin-Based Chemotherapy for Colorectal Liver Metastases: Correlation With Post-Hepatectomy Outcome , 2010, Annals of surgery.

[38]  E. Abdalla,et al.  Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin‐associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis , 2010, Histopathology.

[39]  Allen R. Chen,et al.  Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[40]  M. Dijkgraaf,et al.  Veno‐occlusive disease as a complication of preoperative chemotherapy for Wilms tumor: A clinico‐pathological analysis , 2009, Pediatric blood & cancer.

[41]  G. Kanel,et al.  Bone marrow progenitor cells repair rat hepatic sinusoidal endothelial cells after liver injury. , 2009, Gastroenterology.

[42]  D. Valla,et al.  Vascular disorders of the liver , 2009, Hepatology.

[43]  M. Mejías,et al.  Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats , 2009, Hepatology.

[44]  L. Gaspar,et al.  Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  P. Richardson,et al.  Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation. , 2008, Blood.

[46]  S. Hubscher.  Central perivenulitis: A common and potentially important finding in late posttransplant liver biopsies , 2008 .

[47]  P. Bachellier,et al.  Sinusoidal Injury Increases Morbidity After Major Hepatectomy in Patients With Colorectal Liver Metastases Receiving Preoperative Chemotherapy , 2008, Annals of surgery.

[48]  L. Ellis,et al.  Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin‐based chemotherapy for colorectal liver metastases , 2007, Cancer.

[49]  J. Reichen,et al.  Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products. , 2007, Journal of hepatology.

[50]  S. Pol,et al.  FIB‐4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest , 2007, Hepatology.

[51]  T. Roscioli,et al.  The first prenatal diagnosis for veno‐occlusive disease and immunodeficiency syndrome, an autosomal recessive condition associated with mutations in SP110 , 2007, Prenatal diagnosis.

[52]  D. Manas,et al.  Liver resection for colorectal liver metastasis. , 2007, Surgical oncology.

[53]  R. Soiffer,et al.  Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation. , 2007, Blood.

[54]  T. Pawlik,et al.  Chemotherapy‐associated hepatotoxicity and surgery for colorectal liver metastases , 2007, The British journal of surgery.

[55]  D. Allan,et al.  Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[56]  J. Ziegler,et al.  Mutations in the gene encoding the PML nuclear body protein Sp110 are associated with immunodeficiency and hepatic veno-occlusive disease , 2006, Nature Genetics.

[57]  G. Launoy,et al.  A population‐based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer , 2006, The British journal of surgery.

[58]  B. Nordlinger,et al.  Influence of Preoperative Chemotherapy on the Risk of Major Hepatectomy for Colorectal Liver Metastases , 2006, Annals of surgery.

[59]  A. Helmy.  Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome , 2006, Alimentary pharmacology & therapeutics.

[60]  N. Petrelli,et al.  Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[61]  Y. Caliskan,et al.  Time-related changes in the incidence, severity, and clinical outcome of hepatic veno-occlusive disease in hematopoietic stem cell transplantation patients during the past 10 years. , 2005, Transplantation proceedings.

[62]  Neil Kaplowitz,et al.  Idiosyncratic drug hepatotoxicity , 2005, Nature Reviews Drug Discovery.

[63]  Moo-Song Lee,et al.  Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation , 2005, Annals of Hematology.

[64]  Bernard Paule,et al.  Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy: A Model to Predict Long-term Survival , 2004, Annals of surgery.

[65]  B. George,et al.  Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation. , 2004, Blood.

[66]  T. Ueno,et al.  Innervation of the sinusoidal wall: regulation of the sinusoidal diameter. , 2004, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[67]  J. Berlin,et al.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. , 2004, The New England journal of medicine.

[68]  H. Okajima,et al.  Early graft failure due to a veno‐occlusive disease after a pediatric living donor liver transplantation , 2004, Pediatric transplantation.

[69]  L. Rubbia‐Brandt,et al.  Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[70]  Jeffrey Tsai,et al.  Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome , 2003, Hepatology.

[71]  G. Kanel,et al.  Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition. , 2003, Gastroenterology.

[72]  J. Kalbfleisch,et al.  A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C , 2003, Hepatology.

[73]  R. McCuskey,et al.  Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[74]  T. Gooley,et al.  Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation. , 2003, Blood.

[75]  W. Abebe,et al.  Herbal medication: potential for adverse interactions with analgesic drugs , 2002, Journal of clinical pharmacy and therapeutics.

[76]  Dorena Rode,et al.  Comfrey toxicity revisited. , 2002, Trends in pharmacological sciences.

[77]  M. Remberger,et al.  Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. , 2002, Blood.

[78]  S. Uemoto,et al.  A Successful Liver Transplantation for Refractory Hepatic Veno‐Occlusive Disease Originating from Cord Blood Transplantation , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[79]  Michael A. Choti,et al.  Trends in Long-Term Survival Following Liver Resection for Hepatic Colorectal Metastases , 2002, Annals of surgery.

[80]  G. McDonald,et al.  Hepatic sinusoidal obstruction after gemtuzumab ozogamicin (Mylotarg) therapy. , 2002, Blood.

[81]  Ha Yeon Lee,et al.  A randomized trial of heparin plus ursodiol vs heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation , 2002, Bone Marrow Transplantation.

[82]  G. McDonald,et al.  Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). , 2002, Seminars in liver disease.

[83]  P. D. de Jong,et al.  Source and component genes of a 6–200 Mb gene cluster in the house mouse , 2001, Mammalian Genome.

[84]  S. Rydell,et al.  Prevalence of use of herbal products by adults in the Minneapolis/St Paul, Minn, metropolitan area. , 2001, Mayo Clinic proceedings.

[85]  S. Bearman.  Avoiding hepatic veno-occlusive disease: what do we know and where are we going? , 2001, Bone Marrow Transplantation.

[86]  I. Maruyama,et al.  Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation , 2001, Bone Marrow Transplantation.

[87]  T. Zenz,et al.  Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation--role of transjugular intrahepatic portosystemic shunt (TIPS). , 2001, Liver.

[88]  G. McDonald,et al.  Expanding the use of transjugular intrahepatic portosystemic shunts for veno‐occlusive disease , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[89]  T. Barbui,et al.  Defibrotide for the treatment of hepatic veno‐occlusive disease: results of the European compassionate‐use study , 2000, British journal of haematology.

[90]  F. Stickel,et al.  The efficacy and safety of comfrey , 2000, Public Health Nutrition.

[91]  H. Bismuth,et al.  Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation , 2000, Bone Marrow Transplantation.

[92]  J A Shad,et al.  Acute hepatitis after ingestion of herbs. , 1999, Southern medical journal.

[93]  R. Sackstein,et al.  Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation , 1999, Bone Marrow Transplantation.

[94]  R S McCuskey,et al.  Characterization of a reproducible rat model of hepatic veno‐occlusive disease , 1999, Hepatology.

[95]  K. Ishak,et al.  Recurring fibro-obliterative venopathy in liver allografts. , 1999, The American journal of surgical pathology.

[96]  B. Stegelmeier,et al.  Pyrrolizidine alkaloid plants, metabolism and toxicity. , 1999, Journal of natural toxins.

[97]  A. Gratwohl,et al.  Incidence and Outcome of Hepatic Veno-Occlusive Disease After Blood or Marrow Transplantation: A Prospective Cohort Study of the European Group for Blood and Marrow Transplantation , 1998 .

[98]  D. Neuberg,et al.  Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population. , 1998, Blood.

[99]  C. Fegan,et al.  Parenteral glutamine protects hepatic function during bone marrow transplantation , 1998, Bone Marrow Transplantation.

[100]  N. Callander,et al.  Ursodiol Prophylaxis against Hepatic Complications of Allogeneic Bone Marrow Transplantation , 1998, Annals of Internal Medicine.

[101]  J. Villeneuve,et al.  Hepatitis after the use of germander, a herbal remedy. , 1996, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[102]  A. Nagler,et al.  Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients. , 1996, Transplantation.

[103]  M. Anscher,et al.  Hepatic toxicity resulting from cancer treatment. , 1995, International journal of radiation oncology, biology, physics.

[104]  H. Stuppner,et al.  Reversible hepatic veno-occlusive disease in an infant after consumption of pyrrolizidine-containing herbal tea , 1995, European Journal of Pediatrics.

[105]  G. McDonald,et al.  Venoocclusive disease of the liver after marrow transplantation: Histological correlates of clinical signs and symptoms , 1994, Hepatology.

[106]  G. McDonald,et al.  Veno-occlusive Disease of the Liver and Multiorgan Failure after Bone Marrow Transplantation: A Cohort Study of 355 Patients , 1993, Annals of Internal Medicine.

[107]  Y. Matsumura,et al.  Immunomodulatory effects of ursodeoxycholic acid on immune responses , 1992, Hepatology.

[108]  R. Huxtable.  The Myth of Beneficent Nature: The Risks of Herbal Preparations , 1992, Annals of Internal Medicine.

[109]  P. Brousset,et al.  Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial. , 1992, Blood.

[110]  J. Dipersio,et al.  Orthotopic liver transplantation for life-threatening veno-occlusive disease of the liver after allogeneic bone marrow transplant. , 1991, Bone marrow transplantation.

[111]  M. Labopin,et al.  Prophylactic heparin does not prevent liver veno‐occlusive disease following autologous bone marrow transplantation , 1991, European journal of haematology.

[112]  F. Appelbaum,et al.  Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. , 1990, Blood.

[113]  T. Greenough,et al.  Hepatic venoocclusive disease in autologous bone marrow transplantation of solid tumors and lymphomas. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[114]  B. Swinburn,et al.  Hepatic veno‐occlusive disease associated with comfrey ingestion , 1990, Journal of gastroenterology and hepatology.

[115]  F. Schaffner,et al.  Comfrey herb tea-induced hepatic veno-occlusive disease. , 1989, The American journal of medicine.

[116]  L. Grochow,et al.  VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATION , 1987, Transplantation.

[117]  G. McDonald,et al.  Liver Disease after Human Marrow Transplantation , 1987, Seminars in liver disease.

[118]  B T Cooper,et al.  Veno-occlusive disease of the liver secondary to ingestion of comfrey. , 1987, British medical journal.

[119]  F. Appelbaum,et al.  Venocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation. , 1987, Transplantation.

[120]  Pankaj Sharma,et al.  THE CLINICAL COURSE OF 53 PATIENTS WITH VENOCCLUSIVE DISEASE OF THE LIVER AFTER MARROW TRANSPLANTATION , 1985, Transplantation.

[121]  G. Santos,et al.  Bone marrow transplantation in acute leukemia. , 1982, Seminars in hematology.

[122]  C. Hershko,et al.  Veno-occlusive disease and primary hepatic vein thrombosis in Israeli Arabs. , 1981, Israel journal of medical sciences.

[123]  K. Kopecky,et al.  An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation. , 1980, Gastroenterology.

[124]  W. Woods,et al.  Fatal veno-occlusive disease of the liver following high dose chemotherapy, irradiation and bone marrow transplantation. , 1980, The American journal of medicine.

[125]  Miller Jl,et al.  Fatal veno-occlusive disease of the liver after chemotherapy, whole-body irradiation and bone marrow transplantation for refractory acute leukaemia. , 1979, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[126]  Y. Joshi,et al.  AN EPIDEMIC OF VENO-OCCLUSIVE DISEASE OF LIVER IN CENTRAL INDIA , 1976, The Lancet.

[127]  C. Mellis,et al.  Familial hepatic venoocclusive disease with probable immune deficiency. , 1976, The Journal of pediatrics.

[128]  E. McLean.  The toxic actions of pyrrolizidine (senecio) alkaloids. , 1970, Pharmacological reviews.

[129]  J. Allen,et al.  Hepatic veins of monkeys with veno-occlusive disease. Sequential ultrastructural changes. , 1969, Archives of pathology.

[130]  A. Cox,et al.  The human liver after radiation injury. A form of veno-occlusive disease. , 1966, The American journal of pathology.

[131]  E. Thomas,et al.  Bone marrow transplantation in acute leukemia. , 1965, Cancer research.

[132]  G. Bras,et al.  VENO-OCCLUSIVE LESIONS IN LIVERS OF RATS FED CROTALARIA FULVA. , 1964, British journal of experimental pathology.

[133]  G. Bras,et al.  TOXIC FACTORS IN VENO‐OCCLUSIVE DISEASE , 1963, Annals of the New York Academy of Sciences.

[134]  K. Hizawa,et al.  HEPATIC INJURY FOLLOWING IRRADIATION--A MORPHOLOGIC STUDY--. , 1963, The Tokushima journal of experimental medicine.

[135]  J. B. Gibson.  Chiari's disease and the Budd-Chiari syndrome. , 1960, The Journal of pathology and bacteriology.

[136]  D. Jelliffe,et al.  Veno-occlusive disease of liver with nonportal type of cirrhosis, occurring in Jamaica. , 1954, A.M.A. archives of pathology.

[137]  P. Hahn,et al.  Liver cirrhosis with ascites, induced in dogs by chronic massive hepatic irradiation with radioactive colloidal gold. , 1951, Science.

[138]  R. Parker,et al.  An experimental study of senecio poisoning in rats. , 1951, British journal of experimental pathology.

[139]  D. S. Shillam.  CONGESTIVE SPLENOMEGALY (BANTI'S SYNDROME) DUE TO PORTAL STENOSIS. , 1947, California medicine.

[140]  A. Hess.  FATAL OBLITERATING ENDOPHLEBITIS OF THE HEPATIC VEINS , 1905 .

[141]  E. Want,et al.  Hirmi Valley liver disease: a disease associated with exposure to pyrrolizidine alkaloids and DDT. , 2014, Journal of hepatology.

[142]  P. Richardson,et al.  Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: novel insights to pathogenesis, current status of treatment, and future directions. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[143]  Y. Shibayama,et al.  Focal veno-occlusive lesions following metastasis of cancer in the liver with special reference to obstruction of lymphatics in hepatic veins , 2005, Virchows Archiv A.

[144]  Thomas R. Riley,et al.  A Randomized Double-blind Placebo-controlled Trial , 2004 .

[145]  O. Linderkamp,et al.  Fatal course of veno-occlusive disease of the liver (endophlebitis hepatica obliterans) in a preterm infant. , 1999, Pathology, research and practice.

[146]  D. Berry,et al.  Reduced mortality following bone marrow transplantation for breast cancer with the addition of peripheral blood progenitor cells is due to a marked reduction in veno-occlusive disease of the liver , 1998, Bone Marrow Transplantation.

[147]  K. Ang,et al.  Tolerance of rhesus monkey liver to ionizing radiation , 1993 .

[148]  S. Nimer,et al.  Successful treatment of hepatic venoocclusive disease in a bone marrow transplant patient with orthotopic liver transplantation. , 1990, Transplantation.

[149]  E. Zafrani,et al.  Veno-occlusive disease of the liver following high-dose chemotherapy and autologous bone marrow transplantation in children with solid tumors: incidence, clinical course and outcome. , 1988, Bone marrow transplantation.

[150]  H. Deeg,et al.  Induction of hepatic veno-occlusive disease in dogs. , 1987, The American journal of pathology.

[151]  Pankaj Sharma,et al.  Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing Factors , 1984, Hepatology.

[152]  J. Sterling.  Fetal and infant liver function and structure , 1963 .

[153]  G. Stirling,et al.  The early lesions in veno-occlusive disease of the liver. , 1962, Archives of disease in childhood.